The Dale and Betty Bumpers Vaccine Research Center (VRC) at the National Institutes of Health (NIH) was established to facilitate research in vaccine development. The VRC is dedicated to improving global human health through the rigorous pursuit of effective vaccines for human diseases. Established by former President Bill Clinton as part of an initiative to develop an AIDS vaccine, the VRC is a unique venture within the NIH intramural research program. Initially spearheaded by NIAID, the National Cancer Institute, and the NIH Office of AIDS Research, the VRC is now part of the NIAID organization.
The VRC’s mission is to discover and develop novel vaccines and biologics targeting infectious diseases of global public health importance. The primary areas of research include:
- HIV/AIDS Vaccine Development
- Coronavirus Vaccine Development
- Influenza Vaccine Development
- Pandemic Preparedness
Some highlights from our research can be found on our Scientific Advances at the Vaccine Research Center page.
Latest News Releases
- NIH Statement on HIV Vaccine Awareness Day 2023
May 18, 2023
- Experimental Cancer Vaccine Shows Promise in Animal Studies
November 10, 2022
- Monoclonal Antibody Prevents Malaria Infection in African Adults
October 31, 2022